Ashford Capital Management Inc. Has $3.47 Million Position in Teradyne, Inc. $TER

Ashford Capital Management Inc. lessened its stake in shares of Teradyne, Inc. (NASDAQ:TER) by 41.1% during the first quarter, Holdings Channel.com reports. The fund owned 11,693 shares of the company’s stock after selling 8,163 shares during the period. Ashford Capital Management Inc.’s holdings in Teradyne were worth $3,467,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC lifted its position in shares of Teradyne by 149.1% during the 1st quarter. Cornerstone Planning Group LLC now owns 142 shares of the company’s stock valued at $42,000 after acquiring an additional 85 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of Teradyne in the fourth quarter worth $28,000. SJS Investment Consulting Inc. increased its position in shares of Teradyne by 192.9% in the first quarter. SJS Investment Consulting Inc. now owns 164 shares of the company’s stock worth $49,000 after purchasing an additional 108 shares during the period. Ascentis Independent Advisors bought a new position in shares of Teradyne in the first quarter worth $56,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in Teradyne in the fourth quarter valued at about $37,000. 99.77% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently weighed in on TER. Evercore set a $370.00 price objective on shares of Teradyne in a research report on Thursday, April 30th. JPMorgan Chase & Co. raised shares of Teradyne from a “neutral” rating to an “overweight” rating and set a $400.00 target price on the stock in a report on Thursday, April 30th. Zacks Research upgraded shares of Teradyne from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 12th. Robert W. Baird upped their price target on shares of Teradyne from $350.00 to $446.00 and gave the stock an “outperform” rating in a report on Tuesday, June 23rd. Finally, Stifel Nicolaus increased their price target on shares of Teradyne from $325.00 to $390.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $394.53.

Insider Activity

In other news, VP Ryan Driscoll sold 680 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $377.60, for a total value of $256,768.00. Following the sale, the vice president directly owned 7,665 shares in the company, valued at approximately $2,894,304. This trade represents a 8.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Gregory Stephen Smith sold 4,000 shares of Teradyne stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $423.03, for a total transaction of $1,692,120.00. Following the sale, the chief executive officer directly owned 120,470 shares in the company, valued at $50,962,424.10. This trade represents a 3.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 14,941 shares of company stock worth $5,444,112. Corporate insiders own 0.19% of the company’s stock.

Teradyne Stock Down 4.3%

Shares of TER stock opened at $334.77 on Tuesday. Teradyne, Inc. has a twelve month low of $89.18 and a twelve month high of $487.91. The company has a market cap of $52.40 billion, a P/E ratio of 61.99, a P/E/G ratio of 1.01 and a beta of 1.74. The business has a fifty day simple moving average of $382.69 and a 200 day simple moving average of $334.39.

Teradyne (NASDAQ:TER) last released its quarterly earnings data on Wednesday, April 29th. The company reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.11 by $0.45. Teradyne had a return on equity of 31.79% and a net margin of 22.55%.The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same period last year, the firm posted $0.75 earnings per share. Teradyne’s revenue was up 87.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Teradyne, Inc. will post 7.2 earnings per share for the current fiscal year.

Teradyne Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Thursday, May 21st were issued a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 0.2%. This is an increase from Teradyne’s previous quarterly dividend of $0.12. The ex-dividend date of this dividend was Thursday, May 21st. Teradyne’s dividend payout ratio (DPR) is currently 9.63%.

Teradyne Profile

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.